{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "8709124", "DateCompleted": {"Year": "1996", "Month": "09", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "39", "Issue": "15", "PubDate": {"Year": "1996", "Month": "Jul", "Day": "19"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "Structure-activity relationships of the antimalarial agent artemisinin. 4. Effect of substitution at C-3.", "Pagination": {"StartPage": "2900", "EndPage": "2906", "MedlinePgn": "2900-6"}, "Abstract": {"AbstractText": ["Novel antimalarial artemisinin analogs, 3-alkylartemisinins as well as 3-(arylalkyl)- and 3-(carboxyalkyl)artemisinins, were prepared via the synthetic intermediate 2. Formation of the N,N-dimethylhydrazones 5 and 24 and then regio- and chemoselective deprotonation followed by alkylation provided initially alkylated hydrazones that upon chromatography gave ketones 6-13 and 25-30. Direct ozonolysis of the ketones followed by in situ acidification lead directly to the formation of title compounds 14-21 and 31-36. The analogs were tested in vitro against W-2 and D-6 strains of Plasmodium falciparum and found to be in some cases much more active than the natural product (+)-artemisinin. The results were included in structure-activity relationship (CoMFA) studies for further analog design."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University 38677, USA."}], "Identifier": [], "LastName": "Avery", "ForeName": "M A", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mehrotra", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Bonk", "ForeName": "J D", "Initials": "JD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Vroman", "ForeName": "J A", "Initials": "JA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Goins", "ForeName": "D K", "Initials": "DK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Miller", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Comparative Study", "Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ketones"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "octahydro-3-(3-ethoxypropionyl)-6-methyl-9-butyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "743LRP9S7N", "NameOfSubstance": "Hemin"}, {"RegistryNumber": "9RMU91N5K2", "NameOfSubstance": "artemisinin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": [], "DescriptorName": "Artemisinins"}, {"QualifierName": [], "DescriptorName": "Drug Resistance"}, {"QualifierName": ["chemistry"], "DescriptorName": "Hemin"}, {"QualifierName": [], "DescriptorName": "Hydrogen Bonding"}, {"QualifierName": [], "DescriptorName": "Hydrogen-Ion Concentration"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ketones"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ozone"}, {"QualifierName": ["drug effects"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1996", "Month": "7", "Day": "19"}, {"Year": "1996", "Month": "7", "Day": "19", "Hour": "0", "Minute": "1"}, {"Year": "1996", "Month": "7", "Day": "19", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8709124", "10.1021/jm960200e", "jm960200e"]}}], "PubmedBookArticle": []}